These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 7051369)
1. Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract. Sen P; Smith JK; Buse M; Hsieh HC; Lavenhar MA; Lintz D; Louria DB Sabouraudia; 1982 Jun; 20(2):85-93. PubMed ID: 7051369 [TBL] [Abstract][Full Text] [Related]
2. Effects of human leukocyte dialysates containing transfer factor in the direct leukocyte migration inhibition (LMI) assay. Borkowsky W; Lawrence HS J Immunol; 1979 Oct; 123(4):1741-8. PubMed ID: 479597 [No Abstract] [Full Text] [Related]
3. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay. Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170 [TBL] [Abstract][Full Text] [Related]
4. [The adjuvant and specific activity of transfer factors to Candida albicans antigens]. Borysov VA; Cheusova ZV; Molozhava OS Fiziol Zh (1994); 1998; 44(4):3-9. PubMed ID: 9669168 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs. Sohnle PG; Frank MM; Kirkpatrick CH J Immunol; 1976 Aug; 117(2):523-30. PubMed ID: 781132 [TBL] [Abstract][Full Text] [Related]
6. Transfer of cell-mediated immunity to Paracoccidioides brasiliensis in hamsters with dialysable leukocyte extracts. Peraçoli MT; Montenegro MR; Soares AM; Mota NG J Med Vet Mycol; 1990; 28(1):35-46. PubMed ID: 1694543 [TBL] [Abstract][Full Text] [Related]
7. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides. Wilson GB; Paddock GV; Fudenberg HH Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106 [TBL] [Abstract][Full Text] [Related]
8. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052 [TBL] [Abstract][Full Text] [Related]
9. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor. Horsmanheimo M; Krohn K; Virolainen M; Blomqvist K Arch Dermatol; 1979 Feb; 115(2):180-4. PubMed ID: 426525 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow colony-formation in vitro after infection of genetically defined inbred mice with Candida albicans. Wanasaengsakul S; Ashman RB Microb Pathog; 2004 Apr; 36(4):211-7. PubMed ID: 15001227 [TBL] [Abstract][Full Text] [Related]
11. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice. Dimitrova P; Ivanovska N Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of leukocyte migration by the agarose plate technique. Application to antigen from Candida albicans and Fusobacterium nucleatum. Budtz-Jorgensen E Acta Allergol; 1977 Feb; 32(1):15-26. PubMed ID: 320806 [TBL] [Abstract][Full Text] [Related]
13. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis. Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477 [TBL] [Abstract][Full Text] [Related]
14. A crossreactivity at the immunoglobulin E level of the cell wall mannoproteins of Candida albicans with other pathogenic Candida and airborne yeast species. Kanbe T; Utsunomiya K; Ishiguro A Clin Exp Allergy; 1997 Dec; 27(12):1449-57. PubMed ID: 9433941 [TBL] [Abstract][Full Text] [Related]
15. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans. Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610 [TBL] [Abstract][Full Text] [Related]
16. Fas-FasL interactions modulate host defense against systemic Candida albicans infection. Netea MG; van Der Meer JW; Meis JF; Kullberg BJ J Infect Dis; 1999 Nov; 180(5):1648-55. PubMed ID: 10515828 [TBL] [Abstract][Full Text] [Related]
17. Antigenic variability between Candida albicans blastospores isolated from healthy subjects and patients with Candida infection. Poulain D; Tronchin G; Lefebvre B; Husson MO Sabouraudia; 1982 Sep; 20(3):173-7. PubMed ID: 6753187 [TBL] [Abstract][Full Text] [Related]
18. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene. Doyle TC; Nawotka KA; Kawahara CB; Francis KP; Contag PR Microb Pathog; 2006 Feb; 40(2):82-90. PubMed ID: 16426810 [TBL] [Abstract][Full Text] [Related]
19. [Effect of pepstatin A on Candida albicans infection in the mouse]. Zotter C; Haustein UF; Schönborn C; Grimmecke HD; Wand H Dermatol Monatsschr; 1990; 176(2-3):189-98. PubMed ID: 2194852 [TBL] [Abstract][Full Text] [Related]
20. Low dose of Concanavalin-A enhances innate immune response and prevents liver injury in mice infected with Candida albicans. Conchon-Costa I; Loyola W; Gaziri LC; Custódio LA; Felipe I FEMS Immunol Med Microbiol; 2007 Apr; 49(3):330-6. PubMed ID: 17284281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]